JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study.

The present study documents the morphological changes in the aging human olfactory bulb. Eight bulb pairs from white females between the ages of 25 and 102 years were used. The number of mitral cells in layers IV and III was determined for each bulb and corrected for split cell error. Counts were made on 10-micron thick Nissl-stained sections at 250-micron intervals. The mean number of mitral cells per olfactory bulb at age 25 was estimated from linear regression to be 50,935; at age 60, 32,718; and at age 95, 14,501. The average loss over the time interval studied was 520 mitral cells per year. The volume of each bulb layer, except layer IV, was determined. The difference in the volume of each layer within individuals with age and the total volume with age was not significant (P less than 0.11). The estimated mean bulb volume was found to be 50.02, 43.35, and 36.68 mm3 at ages 25, 60, and 95 years, respectively. The estimated reduction in bulb volume per year increase of age was 0.19 mm3. The ratio of mitral cells to bulb volume for layer III decreased by 19.4 units for every year increase in age. No significant difference was found between the left and the right bulbs in regard to the number of mitral cells and the bulb volume. Histologically, the glomerular layer thickness as well as the mitral cell size and concentration per unit area decreased with age. The intrabulbar anterior olfactory nucleus was discontinuous, highly variable in size, and presumably variable even in neuronal numbers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app